Search for: All records

It has been previously proposed that a megasplay fault within the Cascadia accretionary wedge, spanning from offshore Vancouver Island to Oregon, has the potential to slip during a future Cascadia subduction zone earthquake. This hypothetical fault has major implications for tsunami size and arrival times and is included in disaster-planning scenarios currently in use in the region. This hypothesis is evaluated in this study using CASIE21 deep-penetrating and U.S. Geological Survey high-resolution seismic reflection profiles. We map changes in wedge structural style and seismic character to identify the inner-outer wedge transition zone where a megasplay fault has been previously hypothesized to exist and evaluate evidence for active faulting within this zone. Our results indicate that there is not an active, through-going megasplay fault in Cascadia, but instead, the structure and activity of faulting at the inner-outer wedge transition zone is highly variable and segmented along strike, consistent with the segmentation of other physical and mechanical properties in Cascadia. Wedge sedimentation, plate dip, and subducting topography are proposed to play a major role in controlling megasplay fault development and evolution. Incorporating updated megasplay fault location, geometry, and activity into modeling of Cascadia earthquakes and tsunamis could help better constrain associated hazards. 

Although acquired immunodeficiency syndrome (AIDS) caused by the human immunodeficiency virus (HIV) is a manageable disease for many, it is still a source of significant morbidity and economic hardship for many others. The predominant mode of transmission of HIV/AIDS is sexual intercourse, and measures to reduce transmission are needed. Previously, we showed that caerin 1 antimicrobial peptides (AMPs) originally derived from Australian amphibians inhibited in vitro transmission of HIV at relatively low concentrations and had low toxicity for T cells and an endocervical cell line. The use of AMPs as part of microbicidal formulations would expose the vaginal microbiome to these agents and cause potential harm to protective lactobacilli. Here, we tested the effects of caerin 1 peptides and their analogs on the viability of two species of common vaginal lactobacilli (Lactobacillus rhamnosus and Lactobacillus crispatus). Several candidate peptides had limited toxicity for the lactobacilli at a range of concentrations that would inhibit HIV. Three AMPs were also tested for their ability to inhibit growth of Neisseria lactamica, a close relative of the sexually transmissible Neisseria gonorrhoeae. Neisseria lactamica was significantly more sensitive to the AMPs than the lactobacilli. Thus, several candidate AMPs have the capacity to inhibit HIV and possible N. gonorrhoeae transmission at concentrations that are significantly less harmful to the resident lactobacilli.